Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Invited Presentations

272. Goldenberg RL. Use of antenatal steroids in special circumstances and populations: introduction and definition of the problem.
Presentation at the NIH Consensus Development Conference, Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Washington, DC; February 28-March 2, 1994.

273. Goldenberg RL, Cliver SP, Hickey CA, Andrews W. Examination of the relationship of psychosocial and physiologic factors to preterm delivery using existing datasets.
Seminar at the Centers for Disease Control. Atlanta, GA; April 1994.

274. Goldenberg RL, Cliver SP, Hickey CA, Klerman LV. Examination of the relationship of psychosocial and physiologic factors to preterm delivery using existing datasets.
Workshop on Preterm Delivery and Other Pregnancy Outcomes Among Black Women. Atlanta, GA; May 19, 1995.

275. Goldenberg RL. Antenatal steroid administration.
Grand Rounds at Hospital of St. Raphael, New Haven, CT; January 23, 1996.

276. Goldenberg RL. Invited Presentations: Infection and preterm delivery; and. Strategies to improve outcome related to preterm birth.
Midwinter Seminar in Obstetrics and Gynecology, University of South Florida, St. Petersburg, FL; February 29, 1996.

277. Goldenberg RL. Invited Presentations: An evaluation of strategies to improve low birthweight outcome; and Outcome of Preterm births.
Twenty-first Annual Update in Obstetrics and gynecology, Lake Buena Vista FL; March 13, 1996.

278. Goldenberg RL. An evaluation of strategies to reduce low birthweight.
Grand Rounds, Rochester General Hospital, Rochester, NY; March 20, 1996.

279. Goldenberg RL. Infection and preterm birth.
12th Annual W. Newton Long Lecture, Emory University School of Medicine; March 27, 1996.

280. Goldenberg RL. Invited Presentations: Preterm birth prevention: Does anything work? and Pregnancy outcome and intelligence at age five.
Lagacy Portland Hospital, Portland OR; May 3, 1996.

281. Goldenberg RL. Invited Presentations: An evaluation of strategies to reduce low birthweight; and Infections and preterm birth.
Lonnie Burnett Vanderbilt Ob/Gyn Society, Jacksonville, FL; June 6-7, 1996.

282. Goldenberg RL. An evaluation of strategies to reduce low birthweight deliveries.
University of Michigan, Ann Arbor, MI; June 19-20, 1996.

283. Goldenberg RL. Black/white differences in pregnancy outcome.
Minority Medical Education Program: Health Care Issues-Women's Health, University of Alabama at Birmingham; July 10, 1996.

284. Goldenberg RL. Infection and preterm labor.
University of Florida-Update in Ob/Gyn, San Destin, FL; August 24, 1996.

285. Goldenberg RL. Invited Presentations: Preterm labor prevention: the BV connection; and, Strategies to improve outcomes in low birthweight newborns.
Ambulatory Ob/Gyn Nursing 11th Annual Conference, Washington, DC; October 12, 1996.

286. Goldenberg RL. Invited Presentations: Prediction of prematurity; and Local vaginal pathogens and prematurity.
World Congress in Perinatal Medicine, San Francisco, CA; October 22, 1996.

287. Goldenberg RL. An evaluation of strategies used to improve outcomes associated with low birthweight.
Medical University of South Carolina-1996 Annual Conference of the National Perinatal Association, Nashville, TN; November 7, 1996.

288. Goldenberg RL. Controversies in prematurity.
Invited presentation at the Society of Perinatal Obstetricians; January 21, 1997.

289. Goldenberg RL. Impact of sexually transmitted disease on pregnancy outcome.
Annual Obstetrics and Gynecology Progress Meeting, Birmingham, AL, February 6, 1997.

290. Goldenberg RL. Invited Presentations: Screening for risk of preterm delivery: bacterial vaginosis, cervical ultrasound and fetal fibronectin; Evaluation of strategies aimed at reducing preterm birth; Do antenatal corticosteroids improve perinatal outcome; Should we do antepartum screening for group B Streptococcus?
American College of Obstetricians and Gynecologists Meeting, Beth Israel Health Care Clinical Obstetrician in the Era of Managed Care: Role of Cost-effective and Evidence-based Obstetric Practice, Puerto Rico; February 10-12, 1997.

291. Goldenberg RL. Invited Presentations: Risk factors for preterm labor; and, Understanding the relationship between infection and preterm birth.
Contemporary Forums Health Start/Preterm Delivery Prevention Program, Oakland, CA; April 4, 1997.

292. Goldenberg RL. Invited Presentations: Screening for low birth weight risk; An evaluation of strategies for improving the outcomes of low birthweight deliveries; The use of steroids in the imminent preterm delivery.
National Federation of Perinatal Medicine, Sponsored by the Ministry of Health and the University of Valley, Cali, Columbia; April 23-26, 1997.

293. Goldenberg RL. Low Birthweight PORT: Antenatal Corticosteroid Dissemination Study.
Invited presentation for the AHCPR Pharmaceutical Outcomes Research Group, Rockville, MD; May 22, 1997.

294. Goldenberg RL. Infection and adverse pregnancy outcomes.
Grand Rounds at Tulane University, New Orleans, LA; May 22, 1997

295. Goldenberg RL. Interventions to Prevent Prematurity.
Invited presentation to the AHCPR-supported Conference on "The Effectiveness of Prenatal Care: New Evidence, New Paradigms." Harvard; Boston, MA; June 26-27, 1997.

296. Goldenberg RL. Infection and preterm birth.
Grand Rounds at Medical Center of Central Georgia, Macon, GA; October 8, 1997.

297. Goldenberg RL. Prevention of Preterm Delivery.
Invited presentation to a national invitational conference on "Preterm Birth: Etiology, Mechanisms, and Prevention." Charleston, SC; October 26-28, 1997.

298. Goldenberg RL. Strategies for preterm labor prevention.
Invited presentation to the New England Ob/Gyn Society, Boston, MA; October 29.

299. Goldenberg RL. Low Birthweight PORT. "Selected Accomplishments: A Historical Perspective."
Invited presentation at an AHCPR-sponsored Conference, "Outcomes Research: Engine for Quality Improvement," Washington, DC; October 30-31, 1997.

300. Goldenberg RL. Preventing preterm birth: progress and problems.
Invited presentation at "Innovations in Perinatal Care: Assessing Benefits and Risks," 12th Birth Conference, sponsored by Birth and the Boston University School of Public Health, Boston, MA; June 5-7, 1998.

301. Klerman L. The potential impact of family planning on low birthweight: the PORT approach.
Presentation to the Department of Obstetrics and Gynecology. Los Angeles, CA; August 1993.

302. Klerman L. The PORT approach to low birthweight.
Presentation to the Reproductive Health Branch, Centers for Disease Control; June 1994.

303. Klerman LV. Unintended pregnancies—impact on individual, family and community security. A regional perspective.
Presentation at a conference convened by Region IV of the PHS and the US Department of Education; September, 1995.

304. Klerman LV. Pre- and interception care: their role in improving the health of women and children.
Presentation at the Eighth Annual Thomas A. Leonard M.D. Memorial Lecture at a Plenary Session of the Statewide Perinatal Conference, 26th Annual Meeting of the Wisconsin Association for Perinatal Care. Wisconsin; April 20, 1996.

305. Klerman LV. Pregnancy intendedness: Is it a useful concept?
Presentation at the RAND seminar. Santa Monica, CA; June 1996

306. Klerman LV. The issue of unintended pregnancy in the US and Alabama.
Presentation at the Conference on Increasing Contraceptive Compliance. Auburn University, Montgomery, AL; September 1996.

307. Klerman LV. Unintended pregnancy.
Presentation at a colloquium, University of Alabama School of Social Work. Tuscaloosa, AL; January 1997.

308. Klerman LV. Interconception care and opportunities for family planning.
Invited presentation to the Conference on "The Effectiveness of Prenatal Care: New Evidence, New Paradigms." Harvard; Boston MA; June 26-27, 1997.

309. Klerman LV. What is the meaning of intention status?
Invited presentation at Maternal, Infant, and Child Health Epidemiology Workshop, sponsored by the CDC and other agencies. Atlanta, GA; December 10, 1997.

310. Klerman LV. Unintended pregnancy: is it a useful concept?
Presentation at the School of Public Health, University of North Carolina, Chapel Hill, NC; January 1998.

311. Maher J, Goldenberg RL, Cliver SP, Davis RO, Copper RL. The effect of corticosteroid therapy in the very premature infant.
Presentation at the NIH Consensus Development Conference, Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Washington, DC; February 28-March 2, 1994.

312. Merkatz IR, Atkinson MW. What is the evidence for the effectiveness of maternal combination therapy?
Presentation at the NIH Consensus Development Conference, Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Washington, DC; February 28-March 2, 1994.

313. Nelson KG. Short and long-term outcomes of IUGR.
Invited presentation to the Conference on "The Effectiveness of Prenatal Care: New Evidence, New Paradigms." Harvard; Boston MA; June 26-27, 1997.

314. Ohsfeldt RL, Antel JJ, Gohmann SF. Unintended pregnancies, sample selection, and birth outcomes.
Invited lecture presentation to Project HOPE. Bethesda, MD; December 1997.

315. Rouse DJ. Prevention of early onset neonatal group B streptococcal disease.
Invited presentation to the infectious disease special interest group. Society of Perinatal Obstetricians, Atlanta, GA; January 1995.

Return to Contents

PORT Findings in the Media and Popular Press

Published in National Media and Widely Disseminated Non-Academic Publications

316. Premie research watched. The Bremerton Sun. November 7, 1992.

317. Do adolescent mothers have better outcomes the second time around? UAB's Lister Hill Center for Health Policy 1993;3(7):1.

318. Have we underestimated the cost of low birthweight babies due to maternal smoking? UAB's Lister Hill Center for Health Policy 1994;4(8):1.

319. Is it cost effective to treat pregnancy conditions with bed rest? UAB's Lister Hill Center for Health Policy 1994;4(11):1.

320. Can decision analysis techniques improve physician choices for newborns? UAB's Lister Hill Center for Health Policy. 1994;5(2):1.

321. Routine iron supplementation during pregnancy. Abstracts of Clinical Care Guidelines 1994;6(2):15-18.

322. Comparing options of managing GBS intrapartum. ACOG Newsletter. May 1994;38(5):8.

323. Experts say tocolysis is overused, but ob-gyns are too slow to prescribe corticosteroids. Medical Tribune. June 2, 1994;1(9).1.

324. Bed rest in pregnancy shows little evidence of helping, study finds. New York. July 13, 1994.

325. Better birth weights. Time Magazine 1995.

326. Benefits of antenatal corticosteroids said to far outweigh potential risks. ACM News. June 19, 1995:9.

327. Erythromycin shows no benefit in group B strep in pregnancy. Medical Tribune. July 13, 1995:16.

328. Does prenatal care reduce low birth weight births? Lister Hill Center for Health Policy: UAB Health Policy Research 1995;6(1):1.

329. Low birth weight patient outcomes research team (LBW PORT) enters fourth successful year. Lister Hill Center for Health Policy: UAB Health Policy Research February 1996:3.

330. Are potentially effective therapies being under utilized because of physician practice patterns? Lister Hill Center for Health Policy: UAB Health Policy Research 1996;6(6):1.

331. Low birthweight PORT examines use of prenatal testing and corticosteroids in prevention of preterm birth. AHCPR Research Activities 1996;192:6-7.

332. Sophisticated neonatal ICUs save lives, money, study says. Faulkner & Gray's Medicine & Health 1996;50(39):2.

333. Can we decrease newborn mortality without increasing costs? Lister Hill Center for Health Policy: UAB Health Policy Research 1996;7(1):1.

334. Bed rest dilemma. Julia Porter—like thousands of women—was sent to bed to safeguard her pregnancy. Was it necessary? Washington Post. January 14, 1997:Z12.

335. Bacterial vaginosis and its link to preterm birth. Healthy Mothers, Healthy Babies' Power News. Winter 1997;3(1).

336. Health plan promotes better outcomes: Corticosteroid program uses education, praise. American Health Consultants. March 1997;3(3):33-35.

337. Goldenberg RL. Managing preterm labor: Expert exchange. In: OBG Management, June 1997.

338. Do Nonclinical Factors Influence Practice Variation? Lister Hill Center for Health Policy: UAB Health Policy Research 1998;8(3):1.

Published in Local Media

339. UAB gets $4.8 million grant to help stop prematurity in minority babies. Birmingham Post-Herald. October 27, 1992:B4.

340. Alabama children live riskier lives than most. Birmingham News March 29, 1993:1.

341. Community leaders seek solution to teen pregnancy. Birmingham News May 4, 1995.

342. Another look at unplanned pregnancy. UAB's Synopsis 1995;14(23):3.

343. Antenatal corticosteroids cut morbidity and mortality of premature births. UAB Insight. Fall 1995.

344. Zinc helps moms have bigger, smarter babies. Birmingham News August 9, 1995:1.

345. Birth rate for premies in Alabama triples. Birmingham News September 20, 1995:B2.

346. UAB researchers cast doubt on vitamin value in pregnancy. Birmingham News April 10, 1996.

347. Periodontal disease linked to premature births. UAB's Synopsis 1996;15(43):1.

Return to Contents

Current as of March 1998

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care